RARA and Alzheimer disease: The animals used are refined AD models with low expression of AD-related genes and the studies presented here on prodromal stages of disease add to the accumulating evidence that RA signaling declines early in neurodegeneration leading to the proposal of the use of RAR ligands as therapeutics to boost RA signaling [93].